Compare AGM & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AGM | BHC |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.3B |
| IPO Year | 1995 | 1996 |
| Metric | AGM | BHC |
|---|---|---|
| Price | $198.41 | $7.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 7 |
| Target Price | ★ $257.00 | $8.00 |
| AVG Volume (30 Days) | 97.2K | ★ 3.6M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.11% | N/A |
| EPS Growth | 1.09 | ★ 423.08 |
| EPS | ★ 10.15 | N/A |
| Revenue | N/A | ★ $8,724,000,000.00 |
| Revenue This Year | $29.13 | $7.07 |
| Revenue Next Year | $12.99 | N/A |
| P/E Ratio | $20.25 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $136.57 | $4.33 |
| 52 Week High | $248.29 | $9.04 |
| Indicator | AGM | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 48.78 | 71.70 |
| Support Level | $197.82 | $5.49 |
| Resistance Level | $219.16 | N/A |
| Average True Range (ATR) | 4.55 | 0.39 |
| MACD | 0.96 | 0.21 |
| Stochastic Oscillator | 66.67 | 75.35 |
Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven reportable segments: Farm & Ranch, which generates maximum revenue, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA. Geographically, the company's operations are spread across different regions in the United States.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.